Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gentherm (THRM) Cash & Equivalents (2016 - 2026)

Gentherm has reported Cash & Equivalents over the past 17 years, most recently at $177.4 million for Q1 2026.

  • Quarterly Cash & Equivalents rose 8.74% to $177.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $177.4 million through Mar 2026, up 8.74% year-over-year, with the annual reading at $160.8 million for FY2025, 19.9% up from the prior year.
  • Cash & Equivalents was $177.4 million for Q1 2026 at Gentherm, up from $160.8 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $177.9 million in Q1 2022 and troughed at $123.5 million in Q2 2024.
  • The 5-year median for Cash & Equivalents is $154.2 million (2025), against an average of $152.0 million.
  • Biggest five-year swings in Cash & Equivalents: fell 28.67% in 2022 and later skyrocketed 30.4% in 2025.
  • Tracing THRM's Cash & Equivalents over 5 years: stood at $153.9 million in 2022, then dropped by 2.74% to $149.7 million in 2023, then decreased by 10.38% to $134.1 million in 2024, then increased by 19.9% to $160.8 million in 2025, then grew by 10.3% to $177.4 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $177.4 million, $160.8 million, and $154.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.